The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network
European Journal of Nuclear Medicine and Molecular Imaging · 2026-07 · 53 (8) · 5110-5129
DOI: 10.1007/s00259-026-07885-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 29.04.2026. Verfasst von Pawel J Markiewicz und 34 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Digital Technologies, London South Bank University, London, UK. pawel.markiewicz@lsbu.ac.uk. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Magnetic Resonance Imaging, Dementia, Multimodal Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, Alzheimer's Research UK, Medical Research Council.
Abstract (Originalsprache)
PURPOSE: Positron emission tomography combined with magnetic resonance imaging (PET/MR) has not yet achieved the level of adoption of PET/CT. This study aimed to harmonise PET imaging protocols across a national PET/MR network and to quantitatively assess whether PET/MR can achieve reliability comparable to PET/CT. While previous PET test-retest studies have demonstrated good repeatability, they have typically been limited to small cohorts or restricted site configurations. METHODS: We conducted a multi-site harmonisation and rigorous test-retest study across the network of eight PET/MR scanners. Thirty-seven healthy older participants (65-90 years) underwent harmonised one-hour amyloid PET/MR scans using either [[Formula: see text]F]flutemetamol or [[Formula: see text]F]florbetaben on two occasions. Retest scans were performed under conditions of same-site repeatability or multi-site reproducibility. Harmonised acquisition and reconstruction protocols were applied, and amyloid burden was quantified on the Centiloid (CL) scale. RESULTS: CL values across 74 scans showed excellent test-retest agreement (ICC = 0.968), improving to 0.987 after exclusion of one attenuation correction related outlier. Mean test-retest variability was 2.58%. No statistically significant differences were observed across repeatability versus reproducibility conditions, scanner types, or tracers. CL measurements were highly consistent with three independent blinded visual reads. CONCLUSION: This study demonstrates that harmonised PET/MR achieves high reliability comparable to PET/CT. Although the accuracy of attenuation maps requires checks, this study supports the use of PET/MR for quantitative amyloid imaging in research and therapeutic trials, and provides a valuable open resource of image and raw PET/MR data for further methodological development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Computer Science and Digital Technologies, London South Bank University, London, UK. pawel.markiewicz@lsbu.ac.uk.
- Medical Physics and Biomedical Engineering, Hawkes Institute, University College London, London, UK. pawel.markiewicz@lsbu.ac.uk.
- Nuclear Medicine, Royal Free Hospital, London, UK. pawel.markiewicz@lsbu.ac.uk.
- Institute for Neuroscience and Cardiovascular Research, UK Dementia Research Institute, Edinburgh Imaging, University of Edinburgh, Edinburgh, UK.
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, UK.
- Scottish Brain Sciences, Edinburgh, UK.
ORCID-Profile: Pawel J Markiewicz
Förderung
- Horizon 2020 Framework Programme
- Alzheimer's Research UK
- Medical Research Council
- Alzheimer’s Research UK
- NIHR Newcastle Biomedical Research Centre
- NIHR Cambridge Biomedical Research Centre
- UCLH Biomedical Research Centre
- NIHR Senior Investigator Award
Zitieren
APA
Markiewicz, P. J., Thompson, G., Wardlaw, J. M., Wimberley, C., Ritchie, C., Taylor, J. P., Brooks, D., Maxwell, R., Firbank, M., Hoggard, N., Su, L., Wild, J., Hillel, P., Rhodes-Bradford, V., Parkes, L. M., O'Brien, J. T., Carter, S. F., Aigbirhio, F. I., Fryer, T., …, & Matthews, J. C. (2026). The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network. European Journal of Nuclear Medicine and Molecular Imaging, 53(8), 5110-5129. https://doi.org/10.1007/s00259-026-07885-4
Vancouver
Markiewicz PJ, Thompson G, Wardlaw JM, Wimberley C, Ritchie C, Taylor JP, et al. The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(8):5110-5129. doi:10.1007/s00259-026-07885-4
BibTeX
@article{Markiewicz2026,
author = {Markiewicz, Pawel J and Thompson, Gerard and Wardlaw, Joanna M and Wimberley, Catriona and Ritchie, Craig and Taylor, John-Paul and Brooks, David and Maxwell, Ross and Firbank, Michael and Hoggard, Nigel and Su, Li and Wild, Jim and Hillel, Philip and Rhodes-Bradford, Victoria and Parkes, Laura M and O'Brien, John T and Carter, Stephen F and Aigbirhio, Franklin I and Fryer, Tim and Matthews, Paul M and Malhotra, Paresh and Grey, Gabrielle and Hallett, Will and Ocal, Dilek and Dickson, John C and De Vita, Enrico and Thomas, David L and Fox, Nick C and Krokos, Giorgios and Mackewn, Jane E and Marsden, Paul and Hammers, Alexander and Herholz, Karl and Barkhof, Frederik and Matthews, Julian C},
title = {The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {8},
pages = {5110--5129},
doi = {10.1007/s00259-026-07885-4}
}
EUVIMED